Womens Imaging: Page 74

DBT: Longer reading time, lower breast cancer recall rate

By Rebekah Moan

Interim analysis of a randomized controlled trial on digital breast tomosynthesis (DBT) showed the modality took longer to read than digital mammography but had significantly lower recall rates. The Norwegian researchers also found no differences in radiation dose between the two techniques, thanks to the use of synthesized DBT images.

September 13, 2018

Breast CT firm secures CE certification for new scanner

By AuntMinnieEurope.com staff writers

Advanced Breast-CT (AB-CT) of Erlangen, Germany, has secured CE Mark certification for its breast CT scanner, nu:view.

September 13, 2018

Study rejects mammography's role in reducing mortality

By Rebekah Moan

The findings of a new Danish-Norwegian study are reviving the claim that the recent drop in breast cancer mortality is not due to mammography screening but rather the result of improved treatment. The authors assert it's time to consider alternatives to mammography screening -- such as breast palpation by physicians.

September 12, 2018

Study rejects mammography's role in reducing mortality

By Rebekah Moan

The findings of a new Danish-Norwegian study are reviving the claim that the recent drop in breast cancer mortality is not due to mammography screening but rather the result of improved treatment. The authors assert it's time to consider alternatives to mammography screening -- such as breast palpation by physicians

September 12, 2018

Report details failings behind U.K. breast screening debacle

By AuntMinnieEurope.com staff writers

A new report examining the reasons behind this year's U.K. breast screening debacle pins the blame on an error made in 2013 that continued undetected for five years, according to an article published online on 9 September by Health Service Journal (HSJ).

September 11, 2018

Can Tetris inspire AI for MRI breast cancer detection?

By AuntMinnieEurope.com staff writers

Borrowing concepts used in the classic computer game Tetris, Australian researchers have developed an artificial intelligence (AI) algorithm that they say can detect tumors on breast MRI exams nearly twice as fast as existing breast cancer detection methods without affecting accuracy.

September 9, 2018

DBT + mammo improves cancer detection, increases recalls

By Rebekah Moan

In a substudy of a large digital breast tomosynthesis (DBT) trial, Italian researchers found screen reading using DBT with either acquired or synthesized 2D mammography generally improved breast cancer detection compared with 2D mammography alone but also increased false-positive recalls.

September 9, 2018

Pure Imaging Phantoms reaches milestone

By AuntMinnieEurope.com staff writers

Medical imaging phantom provider Pure Imaging Phantoms has installed its 500th Tomo-Mam phantom for 3D digital breast tomosynthesis (DBT).

September 4, 2018

Study: Mammography screening helps interval cancers too

By AuntMinnieEurope.com staff writers

German mammography screening program participants with invasive breast cancer can generally be treated with less intensive surgical and systemic therapy than nonparticipants, even those with interval cancers, researchers have found.

September 3, 2018

3D-printed models enable blind parents to track baby's growth

By AuntMinnieEurope.com staff writers

Clinicians from Argentina have created 3D-printed models of a fetus' face based on ultrasound scans -- allowing blind parents to track the growth of their unborn child.

September 3, 2018

Supine breast MRI more accurately sizes tumors

By Rebekah Moan

Performing breast MRI on patients in the supine position more accurately determines breast cancer tumor size than prone MRI, according to research from Finland. And because supine MRI demarcates and projects lesions on the skin in the same position used in surgery, it is likely to reduce the need for more operations.

August 30, 2018

New tool calculates breast cancer recurrence

By Rebekah Moan

London researchers have created a web-based calculator that can better predict the long-term risk of breast cancer returning in other areas of the body. The tool, Clinical Treatment Score post-5 years (CTS5), went live on 24 August.

August 23, 2018

Previous Page

Page 74 of 172

Next Page